These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22189225)

  • 1. [Elental prevented and reduced oral mucositis during chemotherapy in patients esophageal cancer].
    Fukui T; Itoh Y; Orihara M; Yoshizawa K; Takeda H; Kawada S; Yoshioka T
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2597-601. PubMed ID: 22189225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of nutritional supplementation for preventing oral mucositis in cancer patients receiving chemotherapy.
    Okada T; Nakajima Y; Nishikage T; Ryotokuji T; Miyawaki Y; Hoshino A; Tokairin Y; Kawada K; Nagai K; Kawano T
    Asia Pac J Clin Nutr; 2017 Jan; 26(1):42-48. PubMed ID: 28049260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
    Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
    Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of combined chemotherapy with nedaplatin, adriamycin, and 5-FU (NAF), and clinical factors affecting its effect in patients with advanced esophageal cancer].
    Hasegawa H; Fujitani K; Hirao M; Nakazuru S; Mita E; Tsujinaka T
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2591-5. PubMed ID: 22189224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of amino-acid-rich elemental diet Elental® on chemotherapy-induced oral mucositis in patients with colorectal cancer: a prospective pilot study.
    Ogata Y; Ishibashi N; Yamaguchi K; Uchida S; Kamei H; Nakayama G; Hirakawa H; Tanigawa M; Akagi Y
    Support Care Cancer; 2016 Feb; 24(2):783-789. PubMed ID: 26266658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
    Maurel J; Cervantes A; Conill C; Salazar R; Martin-Richard M; Pera M; Manzano H; Chirivella I; Gallego R; Marfa X
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):91-6. PubMed ID: 15850907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of Elental on prevention for chemotherapy-induced oral mucositis in colorectal cancer patients].
    Ogata Y; Takeuchi M; Ishibashi N; Kibe S; Takahashi K; Uchida S; Murakami N; Yahara T; Shirouzu K
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):583-7. PubMed ID: 22504682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
    Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y
    Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience.
    Jonak C; Raderer M; Zacherl J; Prager G; Troch M; Ba-Ssalamah A; Hejna M
    Anticancer Res; 2008; 28(6B):4101-4. PubMed ID: 19192667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cryotherapy for prophylaxis of oral mucositis caused by docetaxel, cisplatin, and fluorouracil chemotherapy for esophageal cancer.
    Okamoto K; Ninomiya I; Yamaguchi T; Terai S; Nakanuma S; Kinoshita J; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
    Esophagus; 2019 Apr; 16(2):207-213. PubMed ID: 30600487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laser therapy in the prevention and treatment of mucositis caused by anticancer chemotherapy].
    Ciais G; Namer M; Schneider M; Demard F; Pourreau-Schneider N; Martin PM; Soudry M; Franquin JC; Zattara H
    Bull Cancer; 1992; 79(2):183-91. PubMed ID: 1392157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The preventive effect of allopurinol spray on stomatitis induced by anti-cancer drugs].
    Ito A; Hanawa T; Fujii E
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):563-7. PubMed ID: 11977540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiation for patients with esophageal cancer aged 80 and older.
    Uno T; Kawakami H; Funami Y; Isobe K; Yasuda S; Aruga T; Shimada H; Okazumi S; Nabeya Y; Mastubara H; Ochiai T; Ito H
    Anticancer Res; 2001; 21(6A):4095-7. PubMed ID: 11911299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino acid-rich elemental diet Elental® preserves lean body mass during chemo- or chemoradiotherapy for esophageal cancer.
    Ishikawa T; Yasuda T; Doi T; Okayama T; Sakamoto N; Gen Y; Dohi O; Yoshida N; Kamada K; Uchiyama K; Handa O; Takagi T; Konishi H; Yagi N; Kokura S; Naito Y; Itoh Y
    Oncol Rep; 2016 Aug; 36(2):1093-100. PubMed ID: 27374272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cisplatin, 5-fluorouracil, and high-dose leucovorin for advanced esophageal cancer].
    Yamada R; Yamamoto Y; Morinaga S; Noguchi Y; Yoshida S; Matsumoto A
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):59-63. PubMed ID: 12557706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.
    Shimakawa T; Naritaka Y; Asaka S; Isohata N; Murayama M; Konno S; Yoshimatsu K; Shiozawa S; Katsube T; Ogawa K
    Anticancer Res; 2008; 28(4C):2321-6. PubMed ID: 18751413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
    Sato Y; Takayama T; Sagawa T; Okamoto T; Miyanishi K; Sato T; Araki H; Iyama S; Abe S; Murase K; Takimoto R; Nagakura H; Hareyama M; Kato J; Niitsu Y
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of intravenous and oral administration of ondansetron hydrochloride on chemotherapy-induced nausea and vomiting in patients with esophageal cancer].
    Miyashita M; Onda M; Ikeda K; Bando K; Hagiwara N; Tsuchiya Y; Yoshiyuki T; Kiyama T; Saito T; Sasajima K; Yamashita K
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1629-35. PubMed ID: 10553422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.